Home › Major Depressive Disorder › Utah
Major Depressive Disorder clinical trials in Utah
13 studies for Major Depressive Disorder are looking for participants at sites in Utah.
Cities in Utah
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Boeson Research Pvu, Provo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07621237A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
- Boeson Research, Provo
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 8, 2026 · NCT07076407A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 28, 2026 · NCT07573176Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- University of Utah Hospital, Salt Lake City
Recruiting
Ages 22 to 70 · All sexes · Updated Aug 28, 2026 · NCT064234305-HTP and Creatine for Depression R33 Phase
- University of Utah Department of Psychiatry, Salt Lake City
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 27, 2026 · NCT05895747A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Cedar Clinical Research, Draper
- Inner Space Research, Orem
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Aug 10, 2026 · NCT07592689A Study of Brenipatide in Adult Participants With Major Depressive Disorder
- Alpine Research Organization, Clinton
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 6, 2026 · NCT07412756Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- Andes Clinical Research, Orem
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Aug 3, 2026 · NCT06547489A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Neurocrine Clinical Site, Draper
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07196501A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
- Cedar Clinical Research Inc, Draper
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated May 11, 2026 · NCT06524830Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
- Autobahn Site #159, Orem
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Jan 20, 2026 · NCT06633016Mechanisms of Rumination Change in Adolescent Depression
- University of Utah, Salt Lake City
Recruiting
Ages 14 to 17 · All sexes · Updated Aug 11, 2025 · NCT03859297Study of ALTO-300 in MDD
- Site 207, Clinton
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Jul 24, 2025 · NCT05922878From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.